Table 2.
miRNA | Mechanism | Cell Line | Administration | Carrier Format | Tumor Site | Effect | Reference |
---|---|---|---|---|---|---|---|
miR-124 | overexpression | D425 | In vitro | Lentivirus | Flank/intracranial | Growth inhibition | 73 |
miR-192 | miRNA mimics | D283 | In vivo, intranasal | Nanoparticle | Intracranial | Metastases Inhibition | 85 |
miR-34a | Overexpression | Daoy | In vitro | Adenovirus | Flank/intracranial | Growth inhibition | 54 |
miR-199b-5p | Overexpression | Daoy | In vitro | Adenovirus | Flank/intracranial | Growth inhibition | 52 |
miR-31 | Overexpression | Daoy | In vitro | Transfection | Flank | Growth inhibition | 74 |
miR17‒92 | Anti-miRNA | Ptch1+/−, Trp53 −/− medulloblastoma cells | In vivo, intra venously | LNA | Flank/intracranial | Growth inhibition | 40 |